UNC Lineberger Comprehensive Cancer Center / University of North Carolina is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has participated in 9 clinical trials with 1 currently active.
Therapeutic areas: Disease, Hodgkin, HER2 Positive Breast Cancer, Carcinoma, Non-Small-Cell Lung.
Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer, Astellas Pharma Global Development, Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has 9 clinical trials on record, with 1 currently active. Their work covers Disease, Hodgkin, HER2 Positive Breast Cancer, Carcinoma, Non-Small-Cell Lung.
Yes — UNC Lineberger Comprehensive Cancer Center / University of North Carolina holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.